HFA
TEVA icon

Hoover Financial Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Hoover Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1K Hold
75
– – ﹤0.01% 626
2021
Q1 		$1K Buy
+75
New +$860 ﹤0.01% 579
2020
Q3 		– Sell
-275
Closed -$3K – 438
2020
Q2 		$3K Buy
+275
New +$3.11K ﹤0.01% 433

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Hoover Financial Advisors's TEVA Position: Q2 2021 in Review

Hoover Financial Advisors held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2021 at 75 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Hoover Financial Advisors first reported a position in TEVA in Q2 2020 and has held it in 3 quarters since. The position peaked at $3K in Q2 2020. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Hoover Financial Advisors held 75 shares of Teva Pharmaceutical Industries Limited worth $1K as of Q2 2021.
  • Hoover Financial Advisors left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2021.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #626 holding.
  • Hoover Financial Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2020 and has held it in 3 quarters since.
  • Hoover Financial Advisors's Teva Pharmaceutical Industries Limited position peaked at $3K in Q2 2020.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.